Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
What the field is watching closely: Full peer-reviewed publications Detailed body composition data Long-term safety profiles Cardiometabolic markers Combination studies with existing incretin-based compounds Particularly important: The IGF-1 component introduces powerful biologywhich also means: It will be studied carefully under long-term safety frameworks
3.2 Regeneron / Hansoh (HS-20094 GLP-1/GIP Agonist) Deal: Regeneron (U.S.) in June 2025 licensed global rights (ex-China) to HS-20094 , a dual GLP-1/GIP agonist from Chinas Hansoh Pharma
Semaglutide and berberine is another popular combination
The Food and Drug Administration began a probe into whether GLP-1s cause side effects like aspiration and hair loss in January, CBS News reports
As GLP-1 medication use continues to grow across the country, sweets and snacks are the most affected, explained Leigh Newland ODonnell, head of shopper and category insights at Kantar Retail North America during her session GLP-1 and how it may disrupt your brand.' The prevalence of GLP-1s is expected to impact $6bn in uneaten food sales this year with 46% of users reporting they intend to make better food choices and 43% who said they are overeating less, ODonnell said, citing results from Kantars GLP-1 syndicated study
US$ 24.97
US$ 29.85
US$ 27.18
US$ 24.38
US$ 26.34
